{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T10:11:14Z","timestamp":1784887874689,"version":"3.55.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:00:00Z","timestamp":1775174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["NETP 13204752"],"award-info":[{"award-number":["NETP 13204752"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018315","name":"The University of Toledo College of Medicine and Life Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK124098"],"award-info":[{"award-number":["R01 DK124098"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.neulet.2026.138596","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T16:08:55Z","timestamp":1775059735000},"page":"138596","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effects of chronic levodopa in the paraquat and lectin rat model of the \u201cbody-first\u201d subtype of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"879","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1758-0553","authenticated-orcid":false,"given":"Caroline","family":"Swain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipesh","family":"Pokharel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaibhavi","family":"Peshattiwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khoi","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kala","family":"Venkiteswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thyagarajan","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6_suppl_6","key":"10.1016\/j.neulet.2026.138596_b0005","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1212\/WNL.50.6_Suppl_6.S39","article-title":"Levodopa neurotoxicity: experimental studies versus clinical relevance","volume":"50","author":"Jenner","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2026.138596_b0010","first-page":"1","article-title":"Levodopa in the treatment of Parkinson\u2019s disease","author":"Fahn","year":"2006","journal-title":"Oxidative Stress and Neuroprotection"},{"issue":"13","key":"10.1016\/j.neulet.2026.138596_b0015","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.287.13.1653","article-title":"Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression","volume":"287","author":"Group","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.neulet.2026.138596_b0020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/ana.10609","article-title":"Slower progression of Parkinson's disease with ropinirole versus levodopa: the REAL\u2010PET study","volume":"54","author":"Whone","year":"2003","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.neulet.2026.138596_b0025","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/mds.26497","article-title":"Study of levodopa response in Parkinson's disease: Observations on rates of motor progression","volume":"31","author":"Ding","year":"2016","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.neulet.2026.138596_b0030","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1093\/brain\/awu195","article-title":"The modern pre-levodopa era of Parkinson\u2019s disease: insights into motor complications from sub-Saharan Africa","volume":"137","author":"Cilia","year":"2014","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neulet.2026.138596_b0035","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1056\/NEJMoa1809983","article-title":"Randomized delayed-start trial of levodopa in Parkinson\u2019s disease","volume":"380","author":"Verschuur","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.neulet.2026.138596_b0040","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/mds.29796","article-title":"Long\u2010term follow\u2010up of the LEAP study: early versus delayed levodopa in early Parkinson's disease","volume":"39","author":"Frequin","year":"2024","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.neulet.2026.138596_b0045","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.20527","article-title":"A systematic review of prevalence studies of dementia in Parkinson's disease","volume":"20","author":"Aarsland","year":"2005","journal-title":"Movement Disorders: Official Journal of the Movement Disorder Society"},{"issue":"4","key":"10.1016\/j.neulet.2026.138596_b0050","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/mds.27277","article-title":"Parkinson disease with and without dementia: a prevalence study and future projections","volume":"33","author":"Savica","year":"2018","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.neulet.2026.138596_b0055","first-page":"9","article-title":"Can levodopa prevent cognitive decline in patients with Parkinson\u2019s disease?","volume":"6","author":"Ikeda","year":"2017","journal-title":"Am. J. Neurodegener. Dis."},{"issue":"12","key":"10.1016\/j.neulet.2026.138596_b0060","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1136\/jnnp.2006.098079","article-title":"Effect of levodopa on cognitive function in Parkinson\u2019s disease with and without dementia and dementia with Lewy bodies","volume":"77","author":"Molloy","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neulet.2026.138596_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2024.106101","article-title":"Brain-first vs. body-first Parkinson's disease: an update on recent evidence","volume":"122","author":"Horsager","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.neulet.2026.138596_b0070","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41531-018-0066-0","article-title":"Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat","volume":"4","author":"Anselmi","year":"2018","journal-title":"npj Parkinson's Dis."},{"issue":"10","key":"10.1016\/j.neulet.2026.138596_b0075","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/brain\/awaa238","article-title":"Brain-first versus body-first Parkinson\u2019s disease: a multimodalimaging case-control study","volume":"143","author":"Horsager","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2026.138596_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105557","article-title":"Neuropathological evidence of body-first vs. brain-first Lewy body disease","volume":"161","author":"Borghammer","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2026.138596_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105626","article-title":"Clinical and imaging evidence of brain-first and body-first Parkinson's disease","volume":"164","author":"Horsager","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2026.138596_b0090","article-title":"Characteristics and mechanisms of cognitive impairment in Parkinson disease","author":"Oikonomou","year":"2025","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.neulet.2026.138596_b0095","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.neuroscience.2006.09.024","article-title":"Stereological estimates of the basal forebrain cell population in the rat, including neurons containing choline acetyltransferase, glutamic acid decarboxylase or phosphate-activated glutaminase and colocalizing vesicular glutamate transporters","volume":"143","author":"Gritti","year":"2006","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.neulet.2026.138596_b0100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","article-title":"The efficiency of systematic sampling in stereology and its prediction","volume":"147","author":"Gundersen","year":"1987","journal-title":"J. Microsc."},{"issue":"S2","key":"10.1016\/j.neulet.2026.138596_b0105","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1002\/ana.21455","article-title":"Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis","volume":"64","author":"Goetz","year":"2008","journal-title":"Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society"},{"issue":"1","key":"10.1016\/j.neulet.2026.138596_b0110","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008862","article-title":"The history of Parkinson's disease: early clinical descriptions and neurological therapies","volume":"1","author":"Goetz","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"3","key":"10.1016\/j.neulet.2026.138596_b0115","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archneur.60.3.387","article-title":"Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study","volume":"60","author":"Aarsland","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2026.138596_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104831","article-title":"Longitudinal degeneration of the basal forebrain predicts subsequent dementia in Parkinson's disease","volume":"139","author":"Pereira","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.1016\/j.neulet.2026.138596_b0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ana.410130304","article-title":"Basal forebrain neurons in the dementia of Parkinson disease","volume":"13","author":"Whitehouse","year":"1983","journal-title":"Annals of Neurology: Official Journal of the American Neurological Association and the Child Neurology Society"},{"issue":"7","key":"10.1016\/j.neulet.2026.138596_b0130","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/nan.12513","article-title":"Revisiting the human cholinergic nucleus of the diagonal band of Broca","volume":"44","author":"Liu","year":"2018","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"2","key":"10.1016\/j.neulet.2026.138596_b0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00401-005-0004-1","article-title":"Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies","volume":"111","author":"Fujishiro","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.neulet.2026.138596_b0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0166-4328(88)90105-2","article-title":"Place navigation in rats is impaired by lesions of medial septum and diagonal band but not nucleus basalis magnocellularis","volume":"27","author":"Hagan","year":"1988","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.neulet.2026.138596_b0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0166-4328(90)90073-N","article-title":"Similar memory impairments found in medial septal-vertical diagonal band of Broca and nucleus basalis lesioned rats: are memory defects induced by nucleus basalis lesions related to the degree of non-specific subcortical cell loss?","volume":"37","author":"Riekkinen","year":"1990","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.neulet.2026.138596_b0150","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.expneurol.2010.12.001","article-title":"The effects of chronic levodopa treatments on the neuronal firing properties of the subthalamic nucleus and substantia nigra reticulata in hemiparkinsonian rhesus monkeys","volume":"228","author":"Gilmour","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neulet.2026.138596_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105491","article-title":"The cross-hemispheric nigrostriatal pathway prevents the expression of levodopa-induced dyskinesias","volume":"159","author":"Iyer","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.neulet.2026.138596_b0160","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.parkreldis.2010.04.015","article-title":"A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias","volume":"16","author":"Lieu","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.neulet.2026.138596_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2011.09.013","article-title":"The interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesias","volume":"87","author":"Lieu","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neulet.2026.138596_b0170","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/840247","article-title":"The Antiparkinsonian and Antidyskinetic Mechanisms of Mucuna pruriens in the MPTP-Treated Nonhuman Primate","volume":"2012","author":"Lieu","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.neulet.2026.138596_b0175","article-title":"Polysomnographic Features of sleep Disturbances and REM sleep Behavior Disorder in the Unilateral 6-OHDA Lesioned Hemiparkinsonian Rat","volume":"2014","author":"Vo","year":"2014","journal-title":"Parkinsons Dis"},{"issue":"20","key":"10.1016\/j.neulet.2026.138596_b0180","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1212\/WNL.0000000000012868","article-title":"Dopaminergic therapy for motor symptoms in early Parkinson disease practice guideline summary: a report of the AAN guideline subcommittee","volume":"97","author":"Pringsheim","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.neulet.2026.138596_b0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41531-019-0096-2","article-title":"Acute levodopa dosing around-the-clock ameliorates REM sleep without atonia in hemiparkinsonian rats","volume":"5","author":"Iyer","year":"2019","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.neulet.2026.138596_b0190","article-title":"Behavioral analysis of motor and non-motor impairment in rodent models of Parkinson's disease","volume":"16\u20132024","author":"Sheta","year":"2024","journal-title":"Front. Aging Neurosci."},{"issue":"3","key":"10.1016\/j.neulet.2026.138596_b0195","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.neurobiolaging.2014.12.018","article-title":"Evidence of an association between sleep and levodopa-induced dyskinesia in an animal model of Parkinson's disease","volume":"36","author":"Galati","year":"2015","journal-title":"Neurobiol. Aging"},{"issue":"23","key":"10.1016\/j.neulet.2026.138596_b0200","doi-asserted-by":"crossref","first-page":"3736","DOI":"10.3390\/cells11233736","article-title":"Levodopa-induced dyskinesia in Parkinson\u2019s disease: pathogenesis and emerging treatment strategies","volume":"11","author":"Kwon","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.neulet.2026.138596_b0205","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41598-020-79110-7","article-title":"Cognitive impairment and levodopa induced dyskinesia in Parkinson\u2019s disease: a longitudinal study from the PACOS cohort","volume":"11","author":"Luca","year":"2021","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.neulet.2026.138596_b0210","doi-asserted-by":"crossref","first-page":"e1468","DOI":"10.1212\/WNL.0000000000007189","article-title":"Levodopa-induced dyskinesia is closely linked to progression of frontal dysfunction in PD","volume":"92","author":"Yoo","year":"2019","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neulet.2026.138596_b0215","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00702-023-02633-6","article-title":"The brain-first vs. body-first model of Parkinson\u2019s disease with comparison to alternative models","volume":"130","author":"Borghammer","year":"2023","journal-title":"J. Neural Transm."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394026000959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394026000959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:58:42Z","timestamp":1778543922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394026000959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":43,"alternative-id":["S0304394026000959"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2026.138596","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of chronic levodopa in the paraquat and lectin rat model of the \u201cbody-first\u201d subtype of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2026.138596","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"138596"}}